Marta Serrano

Papers

Total Citations

H-Index

About

Marta Serrano is a leading figure in the advancement of high-throughput analytical and purification technologies for drug discovery. Her research focuses on the integration of reversed-phase high-performance liquid chromatography-mass spectrometry (RP-HPLC-MS) and supercritical fluid chromatography-mass spectrometry (SFC-MS) into automated platforms. Her seminal 2024 paper, "Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery," has already garnered 6 citations, highlighting its immediate impact on streamlining compound analysis and purification in pharmaceutical pipelines. Serrano’s work addresses critical bottlenecks in early-stage drug development, enabling faster, more efficient screening of chemical libraries. By combining orthogonal separation techniques with automated workflows, she has provided researchers with robust tools for both analytical assessment and preparative purification. Her contributions are particularly notable for bridging the gap between analytical chemistry and high-throughput biology, offering practical solutions that accelerate the identification of lead compounds. Serrano’s innovative approach positions her as a key contributor to modern drug discovery infrastructure, with her platform designs influencing both academic and industrial settings. Her ongoing work promises to further refine the speed and reliability of mass spectrometry-guided purification, making her a vital resource for scientists seeking to optimize their discovery pipelines.